Key facts
- It has raised $4.1M; the latest was Seed Round ($4.1M) in Jun 2025.
- Notable investors include UK Research and Innovation, Cultivator, The Nest Family Office, Endgame Capital, Generation-RE Holdings — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Antler Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Antler Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Antler Bio
Developer of an epigenomics technology designed to enhance productivity, efficiency, and sustainability in the livestock industry. The company offers a data-driven platform that integrates gene expression data with actionable insights, digital monitoring tools, and targeted intervention guidance to pinpoint environmental and management factors that limit herd performance, enabling dairy farmers and livestock managers to boost animal health, farm profitability, and sustainability.
- Sector
- Materials and Resources
- HQ
- Dublin, Ireland
- Founded
- 2020
- Employees
- 16
- Website
- antlerbio.com/
- Ownership
- Privately Held (backing)
Antler Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Antler Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Antler Bio in its N-PORT filings yet. We sweep new filings monthly.